Lisa Pieri
Azienda Ospedaliero-Universitaria Careggi(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Kruppel-like factors research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Mutations and prognosis in primary myelofibrosis(2013)741 cited
- → Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis(2014)716 cited
- → Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study(2013)659 cited
- → Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia(2013)406 cited
- → Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis(2014)381 cited
- → Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments(2008)353 cited
- → IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis(2010)312 cited
- → Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele(2009)211 cited
- → Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression(2011)177 cited
- → A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea(2013)174 cited